Name
Geneto OÜ
Registry code
14091673
VAT number
EE101924056
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
04.08.2016 (8)
Financial year
01.01-31.12
Capital
10 932.00 €
Activity
7211 - Research and experimental development on biotechnology 86909 - Other healthcare activities not classified elsewhere
87 807 €
-69 195 €
-79%
2 918 €
(estimate is approximate)
321 961 €
2
Submitted
No tax arrears
-21%
-18%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| OÜ Skywood 11437556 | 7% - 810.00 EUR | - | - | |
| OÜ Võilillekollane 14673211 | 6% - 614.00 EUR | - | - | |
| OÜ MAE 14045325 | 0% - 45.00 EUR | - | - | |
| OÜ Solarcom 10653045 | 4% - 397.00 EUR | - | - | |
| Carduelis Capital OÜ 14782408 | 4% - 397.00 EUR | - | - | |
| Funderbeam Markets AS 12917885 | 0% - 31.00 EUR | - | - | |
| Geneto OÜ 14091673 | 27% - 2 908.00 EUR | - | - | |
| OÜ Tuleleopard 12903500 | 18% - 2 005.00 EUR | - | - | |
| MC Founders OÜ 12803448 | 14% - 1 499.00 EUR | - | - | Founder |
| Sports Gene OÜ 12154628 | 11% - 1 250.00 EUR | - | - | |
| Jaak Sarv 02.10.1978 (46) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Geneto OÜ 14091673 | 27% - 2 908.00 EUR | - | - |
| 2019 27.04.2020 | 2020 29.06.2021 | 2021 27.06.2022 | 2022 30.06.2023 | 2023 29.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 78 860 € | 126 102 € | 162 808 € | 83 852 € | 87 807 € |
| Net profit (loss) for the period | -43 251 € | -69 282 € | -103 462 € | -171 508 € | -69 195 € |
| Profit Margin | -55% | -55% | -64% | -205% | -79% |
| Current Assets | 72 523 € | 91 676 € | 317 352 € | 70 885 € | 10 168 € |
| Fixed Assets | 196 532 € | 276 007 € | 298 769 € | 344 363 € | 365 520 € |
| Total Assets | 269 055 € | 367 683 € | 616 121 € | 415 248 € | 375 688 € |
| Current Liabilities | 27 230 € | 78 140 € | 53 456 € | 24 091 € | 53 727 € |
| Non Current Liabilities | 0 € | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 241 825 € | 289 543 € | 562 665 € | 391 157 € | 321 961 € |
| Employees | 2 | 4 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 19 122.54 € | 13 748.17 € | 9 655.42 € | - |
| 2023 Q4 | 18 433 € | 6 983.99 € | 5 016.17 € | - |
| 2023 Q3 | 19 758.82 € | 5 831.4 € | 3 848.6 € | - |
| 2023 Q2 | 24 172.58 € | 884.69 € | 7 882.12 € | - |
| 2023 Q1 | 25 567.81 € | 17 594.26 € | 15 748.8 € | 3 |
| 2022 Q4 | 22 088.48 € | 18 193.67 € | 18 455.77 € | 3 |
| 2022 Q3 | 24 099.46 € | 15 142.69 € | 15 749.07 € | 3 |
| 2022 Q2 | 16 620.98 € | 15 962.53 € | 16 592.82 € | 2 |
| 2022 Q1 | 26 927.57 € | 12 602.18 € | 12 970.01 € | 5 |
| 2021 Q4 | 36 688.09 € | 15 375.04 € | 11 650.94 € | 4 |
| 2021 Q3 | 27 186.46 € | 14 641.62 € | 12 585.99 € | 4 |
| 2021 Q2 | 50 745.23 € | 12 617.46 € | 7 878.68 € | 4 |
| 2021 Q1 | 81 736.39 € | 17 279.98 € | 8 257.24 € | 5 |
| 2020 Q4 | 16 727.68 € | 10 068.59 € | 10 557.09 € | 5 |
| 2020 Q3 | 9 399.37 € | 12 350.99 € | 11 965.64 € | 5 |
| 2020 Q2 | 39 616.08 € | 9 832.24 € | 10 241.82 € | 5 |
| 2020 Q1 | 47 529.91 € | 8 897.61 € | 9 190.71 € | 4 |
